Transcranial brainstem sonography as a diagnostic tool for amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 15, Issue 3-4, 2014, Pages 244-249

  Prell, Tino ^a   Schenk, Annekathrin ^a   Witte, Otto W ^a   Grosskreutz, Julian ^a   Günther, Albrecht ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Corticospinal tract; Substantia nigra

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; B SCAN; BRAIN STEM; BULBAR PARALYSIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; ECHOGRAPHY; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PRIORITY JOURNAL; PYRAMIDAL TRACT; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; TRANSCRANIAL BRAINSTEM SONOGRAPHY; TRANSCRANIAL MAGNETIC STIMULATION; ULTRASOUND SCANNER; ULTRASOUND TRANSDUCER; CROSS-SECTIONAL STUDY; DIFFUSION WEIGHTED IMAGING; DOPPLER ECHOGRAPHY; ELECTROENCEPHALOGRAPHY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; QUESTIONNAIRE; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; ULTRASTRUCTURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN STEM; CROSS-SECTIONAL STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84901490991     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2014.881499     Document Type: Article

References (32)

1. Brooks BR, Miller RG, Swash M, Munsat T L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9
2. de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. The Awaji criteria for diagnosis of ALS. Muscle Nerve. 2011;44:456-7
3. Dengler R, von Neuhoff N, Bufl er J, Krampfl K, Peschel T, Grosskreutz J. Amyotrophic Lateral Sclerosis: New Developments in Diagnostic Markers. Neurodegenerative Diseases. 2005;2:177-84
4. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942-55
5. Berg D. S ubstantia nigra hyperechogenicity is a risk marker of Parkinson's disease: Yes. J Neural Transm. 2011;118:613-9
6. Walter U, Behnke S, Eyding J, Niehaus L, Postert T, Seidel G, et al. Transcranial brain parenchyma sonography in movement disorders: State of the art. Ultrasound Med Biol. 2007;33:15-25. (Pubitemid 44959319
7. Spiegel J, Hellwig D, Mollers MO, Behnke S, Jost W, Fassbender K, et al. Transcranial sonography and [123I] FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain. 2006;129:1188-93
8. Berg D, Merz B, Reiners K, Naumann M, Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord. 2005;20:383-5
9. Berg D, Godau J, Walter U. T ranscranial sonography in movement disorders. Lancet Neurol. 2008;7:1044-55
10. Vucic S, Ziemann U, Eisen A, Hallett M, Kiernan MC. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: Pathophysiological insights. J Neurol Neurosurg Psychiatry. 2012;84:1161-70
11. Berg D. H yperechogenicity of the substantia nigra: Pitfalls in assessment and specifi city for Parkinson's disease. J Neural Transm. 2011;118:453-61
12. Fathinia P, Hermann A, Reuner U, Kassubek J, Storch A, Ludolph AC. Parkinson's disease-like midbrain hyperechogenicity is frequent in amyotrophic lateral sclerosis. J Neurol. 2013;260:454-7
13. Park HK, Lim YM, Kim JS, Lee MC, Kim SM, Kim BJ, et al. Nigrostriatal dysfunction in patients with amyotrophic lateral sclerosis and Parkinsonism. J Neurol Sci. 2011;301:12-3
14. Hideyama T, Momose T, Shimizu J, Tsuji S, Kwak S. A positron emission tomography study on the role of nigral lesions in Parkinsonism in patients with amyotrophic lateral sclerosis. Arch Neurol. 2006;63:1719-22. (Pubitemid 44925079
15. Kato S, Oda M, Tanabe H. D iminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 1993;19:300-4. (Pubitemid 23237480
16. Shintaku M, Oyanagi K, Kaneda D. A myotrophic lateral sclerosis with dementia showing clinical Parkinsonism and severe degeneration of the substantia nigra: Report of an autopsy case. Neuropathology. 2007;27:295-9. (Pubitemid 46800489
17. Schulte-Mattler WJ, Muller T, Zierz S. T ranscranial magnetic stimulation compared with upper motor neuron signs in patients with amyotrophic lateral sclerosis. J Neurol Sci. 1999;170:51-6. (Pubitemid 29502535
18. Kaufmann P, Pullman SL, Shungu DC, Chan S, Hays AP, Del Bene ML, et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology. 2004;62:1753-7. (Pubitemid 38661730
19. Abe K, Fujimura H, Kobayashi Y, Fujita N, Yanagihara T. Degeneration of the pyramidal tracts in patients with amyotrophic lateral sclerosis. A pre mortem and post mortem magnetic resonance imaging study. J Neuroimaging. 1997;7:208-12. (Pubitemid 27449660
20. Hecht MJ, Fellner F, Fellner C, Hilz MJ, Heuss D, Neundorfer B. MRI-FLAIR images of the head show corticospinal tract alterations in ALS patients more frequently than T2-, T1-And proton-density-weighted images. J Neurol Sci. 2001;186:37-44. (Pubitemid 32544940
21. Hecht MJ, Fellner F, Fellner C, Hilz MJ, Neundorfer B, Heuss D. Hyperintense and hypointense MRI signals of the precentral gyrus and corticospinal tract in ALS: A follow-up examination including FLAIR images. J Neurol Sci. 2002;199:59-65. (Pubitemid 34669839
22. Waragai M. M RI and clinical features in amyotrophic lateral sclerosis. Neuroradiology. 1997;39:847-51. (Pubitemid 27528523
23. Wang S, Melhem ER, Poptani H, Woo JH. N euroimaging in amyotrophic lateral sclerosis. Neurotherapeutics. 2011;8:63-71
24. Wang S, Melhem ER. A myotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers. Ann N Y Acad Sci. 2005;1064:61-77. (Pubitemid 43030949
25. Neema M, Guss ZD, Stankiewicz JM, Arora A, Healy BC, Bakshi R. Normal fi ndings on brain fl uidattenuated inversion recovery MR images at 3T. AJNR Am J Neuroradiol. 2009;30:911-6
26. Kassubek J, Bretschneider V, Sperfeld AD. C orticospinal tract MRI hyperintensity in X-linked Charcot-Marie-Tooth Disease. J Clin Neurosci 2005;12:588-9. (Pubitemid 41044208
27. Agosta F, Chio A, Cosottini M, D e Stefano N, Falini A, Mascalchi M, et al. The present and the future of neuroimaging in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2010;31:1769-77
28. Appel SH, Zhao W, Beers DR, Henkel JS. The microglial-motoneuron dialogue in ALS. Acta Myol. 2011;30:4-8
29. Hadzhieva M, Kirches E, Wilisch-Neumann A, Pachow D, Wallesch M, Schoenfeld P, et al. Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis. Neuroscience. 2012;230:94
30. Nadjar Y, Gordon P, Corcia P, Bensimon G, Pieroni L, Meininger V, et al. Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosis. PLoS One 2012;7:e45034
31. Oshiro S, Morioka MS, Kikuchi M. D ysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Adv Pharmacol Sci. 2011;378278
32. Lautenschlaeger J, Prell T, Grosskreutz J. E ndoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13:166-77.